Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: Modification of the two-hit hypothesis

Clinical Cancer Research

Volumn 16, Issue 2, 2010, Pages 442-450

  Pan, Shuang ^a,b   Dong, Qing ^a   Sun, Li Sha ^a   Li, Tie Jun ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN PATCHED 1;

ADOLESCENT; ADULT; ARTICLE; BASAL CELL NEVUS SYNDROME; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INACTIVATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MALE; METHYLATION; ODONTOGENIC KERATOCYST; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ALLELES; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; CHILD; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENETIC PREDISPOSITION TO DISEASE; GINGIVAL NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MODELS, GENETIC; MUTATION; ODONTOGENIC TUMORS; RECEPTORS, CELL SURFACE; YOUNG ADULT;

EID: 74549200943     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2574     Document Type: Article

References (38)

1. Woolgar JA, Rippin JW, Browne RM. The odontogenic keratocyst and its occurrence in the nevoid basal cell carcinoma syndrome. Oral Surg Oral Med Oral Pathol 1987;64:727-30.
2. Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 2004;6:530-659.
3. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-51.
4. Gailani MR, Bale SJ, Leffell DJ, et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 1992;69:111-7.
5. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820-23.
6. Levanat S, Gorlin RJ, Fallet S, Johnson DR, Fantasia JE, Bale AE. A two-hit model for developmental defects in Gorlin syndrome. Nat Genet 1996;12:85-7.
7. Browne RM. The odontogenic keratocyst. Histological features and their correlation with clinical behaviour. Br Dent J 1971;131:249-59.
8. Li TJ, Browne RM, Matthews JB. Epithelial cell proliferation in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. J Oral Pathol Med 1995;24:221-6.
9. Gu XM, Zhao HS, Sun LS, Li TJ. PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts. J Dent Res 2006;85:859-63.
10. Li TJ, Yuan JW, Gu XM, Sun LS, Zhao HS. PTCH germline mutations in Chinese nevoid basal cell carcinoma syndrome patients. Oral Dis 2008;14:174-9.
11. Sun LS, Li XF, Li TJ. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. J Dent Res 2008;87:575-9.
12. Pan S, Li TJ. PTCH1 mutations in odontogenic keratocyst: are they related to epithelial cell proliferation? Oral Oncol 2009;45:861-5.
13. Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L. PTCH gene mutations in odontogenic keratocysts. J Dent Res 2000;79:1418-22.
14. Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N, Ooya K. PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg 2004;33:584-92.
15. Song YL, Zhang WF, Peng B, Wang CN, Wang Q, Bian Z. Germline mutations of the PTCH gene in families with odontogenic keratocysts and nevoid basal cell carcinoma syndrome. Tumour Biol 2006;27: 175-80.
16. Chenevix-Trench G, Wicking C, Berkman J, et al. Further localization of the gene for nevoid basal cell carcinoma syndrome (NBCCS) in 15 Australasian families: linkage and loss of heterozygosity. Am J Hum Genet 1993;53:760-7.
17. Vorechovský I, Tingby O, Hartman M, et al. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours. Oncogene 1997;15:361-6.
18. Danaee H, Karagas MR, Kelsey KT, Perry AE, Nelson HH. Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin. J Invest Dermatol 2006;126: 1152-8.
19. Fodde R, Smits R. Cancer biology. A matter of dosage. Science 2002;298:761-3.
20. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
21. Calzada-Wack J, Kappler R, Schnitzbauer U, et al. Unbalanced over-expression of the mutant allele in murine Patched mutants. Carcinogenesis 2002;23:727-33.
22. Zurawel RH, Allen C, Wechsler-Reya R, Scott MP, Raffel C. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice. Genes Chromosomes Cancer 2000;28:77-81.
23. Hime GR, Lada H, Fietz MJ, et al. Functional analysis in Drosophila indicates that the NBCCS/PTCH1 mutation G509V results in activation of smoothened through a dominant-negative mechanism. Dev Dyn 2004;229:780-90.
24. Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997;69:299-308.
25. Louhelainen J, Lindström E, Hemminki K, Toftgård R. Dinucleotide repeat polymorphism within the tumor suppressor gene PTCH at 9q22. Clin Genet 1998;54:239-41.
26. Barnes L, Eveson JW, Reichart P, et al. World Health Organization classification of tumours: pathology and genetics of tumours of the head and neck. pp. 330-86Lyon: IARC Press; 2005.
27. Quon KC, Berns A. Haplo-insufficiency? Let me count the ways. Genes Dev 2001;15:2917-21.
28. Wolf I, Bose S, Desmond JC, et al. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Res Treat 2007;105:139-55.
29. Cretnik M, Musani V, Oreskovic S, Leovic D, Levanat S. The Patched gene is epigenetically regulated in ovarian dermoids and fibromas, but not in basocellular carcinomas. Int J Mol Med 2007;19:875-83.
30. Pritchard JI, Olson JM. Methylation of PTCH1, the Patched-1 gene, in a panel of primary medulloblastomas. Cancer Genet Cytogenet 2008;180:47-50.
31. Wetmore C, Eberhart DE, Curran T. The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched. Cancer Res 2000;60:239-46.
32. Johnson RL, Zhou L, Bailey EC. Distinct consequences of sterol sensor mutations in Drosophila and mouse patched homologs. Dev Biol 2002;242:224-35.
33. Johnson RL, Milenkovic L, Scott MP. In vivo functions of the patched protein: requirement of the C terminus for target gene inactivation but not Hedgehog sequestration. Mol Cell 2000;6:467-78.
34. Evans DG, Maher ER, Baser ME. Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms. J Med Genet 2005;42:630-2.
35. Xu LL, Li TJ. PTCH2 gene alterations in keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome. Beijing Da Xue Xue Bao 2008;40:15-8.
36. Tostar U, Malm CJ, Meis-Kindblom JM, Kindblom LG, Toftgård R, Undén AB. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. J Pathol 2006;208:17-25.
37. Toftgard R. Hedgehog signalling in cancer. Cell Mol Life Sci 2000;57: 1720-31.
38. Williams JA, Guicherit OM, Zaharian BI, et al. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci U S A 2003; 100:4616-21.